GlassScriptPhysician profile
Mitchell Andrew Pet
NPI 1134428758
$42,009.86
in general payments reported to CMS, 2019-2025
21 companies · $37K in 2025
The $37K reported for 2025 was more than what 98% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $876 · 2020: $722 · 2021: $1,574 · 2022: $760 · 2023: $754 · 2024: $658 · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Food and Beverage: $3,008 · Travel and Lodging: $1,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,600.00 |
| Food and Beverage | $3,008.12 |
| Travel and Lodging | $1,470.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vioptix INC | $33,675.78 | 2023-2025 | |
| Elite Orthopedics, LLC | $1,835.55 | 2020-2024 | |
| Trimed, INC. | $1,722.47 | 2019-2025 | |
| Endo USA, INC. | $1,077.33 | 2025 | Xiaflex |
| Axogen | $1,001.85 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Sientra, INC. | $426.19 | 2020-2022 | |
| Integra Lifesciences Corporation | $334.08 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $317.05 | 2025 | Novosorb Btm |
| Kci USA, INC. | $210.65 | 2022-2023 | V.A.C. Veraflo, Prevena, Prevena Restor Bellaform |
| Rti Surgical, INC | $187.17 | 2024 | |
| Biocircuit Technologies INC | $182.58 | 2025 | Nerve Tape |
| Allergan, INC. | $172.38 | 2019-2021 | |
| Baxter Healthcare | $163.55 | 2019 | |
| Acera Surgical, INC. | $157.09 | 2023 | Restrata Wound Matrix |
| Davol INC. | $150.02 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $145.19 | 2022 | |
| Zimmer Biomet Holdings, INC. | $144.37 | 2024 | A.L.P.S. |
| Kerecis Limited | $52.51 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $36.83 | 2023 | |
| Stryker Corporation | $17.22 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Pet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.